IVITF - Invictus MD Strategies Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0401
-0.0049 (-10.89%)
At close: 3:24PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0450
Open0.0425
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0350 - 0.0500
52 Week Range0.0010 - 0.3970
Volume30,586
Avg. Volume62,953
Market Cap4.996M
Beta (5Y Monthly)5.36
PE Ratio (TTM)N/A
EPS (TTM)-0.1410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 17, 2016
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • CNW Group

      Invictus MD Strategies Corp. - Change of Management

      The Company wishes to thank Ms. Toor for her service. The Company's Controller, Ms. Elena Gershtein has been appointed Acting CFO. Elena has a Bachelor of Commerce Degree in Accountancy from the University of British Columbia .

    • CNW Group

      Invictus Announces Director Resignation

      Invictus Announces Director Resignation

    • CNW Group

      Invictus MD Strategies Corp. - Notice of Sale and Investment Solicitation Process

      VANCOUVER , March 24, 2020 /CNW/ - INVICTUS MD STRATEGIES CORP. (NEX: GENE.H;) (the "Company") announced that the Company, Greener Pastures MD Ltd., Acreage Pharms Ltd. ("Acreage") and 2015059 Alberta Ltd. (collectively, the "Invictus Group") have received an order (the "Order") from the Supreme Court of British Columbia (the "Court") that approves the Invictus Group's proposed sale and investment solicitation process ("SISP") in respect of their businesses and assets in connection with the Invictus Group's ongoing Companies' Creditors Arrangement Act ("CCAA") proceedings. Under the SISP, the Invictus Group, together with its Chief Restructuring Officer ("CRO") has commenced soliciting proposals from potential interested parties for the acquisition of, or investment in, the Invictus Group or their respective businesses and assets, all in accordance with the process and timelines provided for in the Order.

    • CNW Group

      Invictus Announces Resignations

      Invictus Announces Resignations

    • Newsfile

      Invictus Obtains Further Court Approvals in Connection with CCAA Proceedings

      Vancouver, British Columbia--(Newsfile Corp. - February 25, 2020) - INVICTUS MD STRATEGIES CORP. (TSXV: GENE) (OTCQX: IVITF) (FSE: 8IS2) (the "Company") announces that on Monday, February 24, 2020, the Supreme Court of British Columbia (the "Court") granted an amended and restated initial order (the "Amended and Restated Initial Order") under the Companies' Creditors Arrangement Act (Canada) ("CCAA"). The Amended and Restated Initial Order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd. ("Acreage"), and ...

    • GlobeNewswire

      INVICTUS GRANTED CREDITOR PROTECTION AND WILL COMMENCE A STRATEGIC REVIEW

      Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “Company”) announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the “Court”) issued an order granting the Company’s application for creditor protection under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). The order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd. (“Acreage”), and 2015059 Alberta Ltd. (together with the Company, the “Invictus Group”).

    • GlobeNewswire

      INVICTUS ANNOUNCES TERMINATION OF THE PREVIOUSLY ANNOUNCED BINDING LETTER OF INTENT WITH UNIFIED CANNABIS CORP.

      Vancouver, B.C., Jan. 03, 2020 -- Vancouver, BC, January 3, 2020 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) further to.

    • GlobeNewswire

      INVICTUS ANNOUNCES $5,700,000 CONVERTIBLE DEBENTURE FINANCING

      Vancouver, B.C., Dec. 16, 2019 -- Vancouver, BC, December 16, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased.

    • GlobeNewswire

      INVICTUS ANNOUNCES CHANGE TO BOARD

      Vancouver, B.C., Dec. 13, 2019 -- Vancouver, BC, December 13, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced.

    • GlobeNewswire

      INVICTUS ANNOUNCES THE RETURN OF TREVOR DIXON TO THE BOARD OF DIRECTORS

      Vancouver, B.C., Dec. 02, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that Trevor Dixon is returning to.

    • GlobeNewswire

      INVICTUS CLOSES TERMINATION OF AUTHENTIC BRANDS GROUP LICENSE AGREEMENT

      INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective September 30, 2019, of the previously announced termination of its license agreement with ABG-HMX, LLC pursuant to an omnibus settlement and termination agreement (the “Agreement”). The Company sought and received regulatory approval from the TSX Venture Exchange to complete the termination. Further to the description of the terms and conditions of the Agreement in the Company's news release dated October 23, 2019, in accordance with TSXV requirements, the Agreement was amended to institute a minimum per share issue price of $0.12 as opposed to $0.11625 for any share consideration issued in connection with the Company’s payment obligations under the Agreement.

    • GlobeNewswire

      INVICTUS PROVIDES UPDATE ON ACREAGE PHARMS LTD. AND AB LABORATORIES INC.

      INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”) has hired Kris Love as Vice-President of Production effective August 1, 2019. Mr. Love has many years of experience in cannabis production in Canada and already has become an integral asset to the Company’s operation.

    • GlobeNewswire

      INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT

      FRA: 8IS2) The Company  and ABG-HMX, LLC (“ABG”) have mutually agreed to an early termination of the license agreement dated June 1, 2018 (the “License Agreement”)  pursuant to an omnibus settlement and termination agreement (the “Termination Agreement”).  The Company continues to focus on increasing shareholder value by providing quality cannabis and oil to meet the demand of sales to the medical and recreational markets.

    • GlobeNewswire

      INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

      Vancouver, B.C., Oct. 17, 2019 -- Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company.

    • Imagine Owning Invictus MD Strategies (CVE:GENE) And Trying To Stomach The 89% Share Price Drop
      Simply Wall St.

      Imagine Owning Invictus MD Strategies (CVE:GENE) And Trying To Stomach The 89% Share Price Drop

      It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...

    • GlobeNewswire

      INVICTUS ANNOUNCES APPOINTMENT OF INTERIM CEO AND ALTERNATE DIRECTOR

      Vancouver, B.C., Oct. 08, 2019 -- Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces.

    • GlobeNewswire

      INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

      Vancouver, B.C., Sept. 24, 2019 --   Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the.

    • GlobeNewswire

      INVICTUS ENTERS INTO AGREEMENT TO SELL FUTURE HARVEST DEVELOPMENT LTD.

      FRA: 8IS1) announces that, the Company has agreed to sell the 82.5% issued and outstanding shares (the “Future Harvest Shares”) of Future Harvest Development Ltd. (“Future Harvest”) which are held by the Company’s wholly owned subsidiary Prestige Worldwide Holdings Inc. (“Prestige”) to SL 152 Ventures Ltd. (“SL 152”), a company owned by Mr. Byron Sheppard, a Director, President and CEO of Future Harvest, and whose company holds the remaining 17.5% of Future Harvest.

    • GlobeNewswire

      INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE

      FRA: 8IS2) is pleased to announce that AB Laboratories Inc. (“AB Labs”) a company which is a 50% owned subsidiary of Invictus has received their amended license from Health Canada to include the new 40,000 sq. ft. custom built cultivation facility located near Hamilton, Ontario. As previously announced on June 26, 2019, AB Labs’ facility contains ten identical cultivation rooms capable of producing over 65 crops annually on a tightly controlled weekly production schedule.  Five rooms have been propagated since receiving the amended license on August 30, 2019.  The initial harvest is scheduled for November 1, 2019.  The remaining rooms are expected to be propagated at a rate of one room per week over the next five weeks to ensure a reliable continuous production of cannabis for the recreational and medical markets.

    • GlobeNewswire

      INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS

      Vancouver, B.C., Aug. 30, 2019 -- Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces.

    • GlobeNewswire

      ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL

      FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage"), the Company's wholly-owned subsidiary, has signed a non-binding term sheet (the "Term Sheet") for a secured term loan of up to $6.0 million (the “Loan Amount”) with an interest rate of 10.0% per annum (the “Term Loan”) on drawn amounts with Trichome Financial Corp. ("Trichome Financial"). Invictus has also signed the Term Sheet as a guarantor of the Term Loan.  The funds drawn on the Term Loan will be used for the completion of the 90,000 square foot Phase III cultivation facility near Edson, Alberta, including the purchase of automated processing equipment and the development of the EU-GMP facility with the remainder to be used for general working capital purposes for both Acreage and the Company.

    • Benzinga

      The Week Ahead In Cannabis: Lottery In Ontario, Corporate Updates And Earnings

      The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...

    • GlobeNewswire

      ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

      Vancouver, B.C., Aug. 14, 2019 -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.

    • GlobeNewswire

      GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS

      Vancouver, B.C., Aug. 12, 2019 -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing.

    • GlobeNewswire

      ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY

      Vancouver, Aug. 06, 2019 -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.